Dr. Andrew Hilmer Presents Technology Seminar
2903 THSL
The Doctoral Program in Cancer Biology Welcomes Andrew J. Hilmer, PhD, Senior Account Manager of Applied StemCell, Inc. He will be presenting a technology seminar "Re-Writing the Genome: CRISPR/Cas9, Targeted Integrases, and their Application to Next Generation Cell Line and Animal Models"